“…With respect to oral vaccines against enteric bacterial pathogens, experimental challenge models involving community volunteers have been established for cholera (Levine et al, 1979a(Levine et al, , 1981a(Levine et al, , 1981b, Shigella (Kotloff et al, 1995), ETEC (Harro et al, 2011a;Levine et al, 1977Levine et al, , 1979b, C. jejuni (Black et al, 1988;Tribble et al, 2010b), and S. Typhi (Pollard et al, 2012;Waddington et al, 2014). These models have proved highly useful for identifying protective activity of oral vaccine candidates and served as the basis for the licensure of the CVD 103-HgR oral cholera vaccine in multiple countries for use in travelers.…”